KRAS and neoplasm: Several tumor hallmarks, such as mTORC1, PI3K-AKT-mTOR and KRAS, were activated in MPC3, and other tumor biological processes, including hypoxia, peroxisomes, MYC targets and oxidative phosphorylation, were upregulated in MPC3 (Fig. 5A).